NCT06862700View on ClinicalTrials.gov

Effect of Reduced Vasopressors on Mortality in ECMO-supported Cardiogenic Shock Patients

RecruitingOBSERVATIONAL
Enrollment

534

Participants

Timeline

Start Date

February 26, 2025

Primary Completion Date

January 1, 2027

Study Completion Date

January 1, 2028

Conditions
Cardiogenic ShockExtracorporeal Membrane OxygenationVasopressorsHemodynamic ManagementCritical CareHeart Failure
Interventions
OTHER

Vasopressor Exposure Levels

This is an observational study with no active intervention. The study evaluates the association between natural variations in vasopressor exposure levels (measured by Vasoactive-Inotropic Score, VIS) and clinical outcomes in patients receiving VA-ECMO for cardiogenic shock.

Trial Locations (1)

100029

RECRUITING

Beijing Anzhen Hospital, Beijing

All Listed Sponsors
lead

Xiaotong Hou

OTHER